'Large trials' diaporamas de présentation

Integrative Medicine and Psychiatry: An Evidence Based Approach Part I

Integrative Medicine and Psychiatry: An Evidence Based Approach Part I. Marlene P. Freeman, M.D. Associate Professor, Harvard Medical School Director of Clinical Services, Perinatal and Reproductive Psychiatry Program; Medical Director, CTNI Massachusetts General Hospital.

738 views • 61 slides

Topics in Clinical Trials (7 ) - 2012

Topics in Clinical Trials (7 ) - 2012. J. Jack Lee, Ph.D. Department of Biostatistics University of Texas M. D. Anderson Cancer Center. Multiple Significance Testings. Interim analysis Subgroup analysis Multiple endpoints Silent multiplicity Implications

479 views • 35 slides

Pilot Studies Nuts and Bolts

Pilot Studies Nuts and Bolts. Deborah Grady, MD, MPH Professor of Medicine Associate Dean for Clinical and Translational Research UCSF. Pilot Studies. Small studies aimed at helping you: plan the best study possible determine that the study can be done get funding for your study

552 views • 34 slides

Lecture 10: Meta-analysis of intervention studies

Lecture 10: Meta-analysis of intervention studies. Introduction to meta-analysis Selection of studies Abstraction of information Quality scores Methods of analysis and presentation Sources of bias. Definitions. Traditional (narrative) review: Selective, biassed

450 views • 33 slides

Lecture 10: Meta-analysis of intervention studies

Lecture 10: Meta-analysis of intervention studies. Introduction to meta-analysis Selection of studies Abstraction of information Quality scores Methods of analysis and presentation Sources of bias. Definitions. Traditional (narrative) review: Selective, biassed

463 views • 30 slides

Vitamin E and Selenium Nov 6, 2013

430 views • 27 slides

Common Questions in Lipids 2010

Common Questions in Lipids 2010. Mehul Bhatt, MD Athens Heart Center. Contemporary Guidelines (simple enough). National Cholesterol Education Program (NCEP) 2004 LDL < 70-100 mg/ dL for CAD and CAD-equivalent risk factors < 100-130 mg/ dL for 2+ CAD risk factors

257 views • 20 slides